HHS Should Track All Rx Clinical Trials, AMA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
All trials should be registered to ensure results are publicly available, physicians’ association says. Institutional review boards should not approve trials unless they are registered, AMA policy urges.